QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
NASDAQ:CNTG

Centogene (CNTG) Stock Price, News & Analysis

$0.46
-0.01 (-1.11%)
(As of 03:41 PM ET)
Today's Range
$0.43
$0.48
50-Day Range
$0.46
$1.03
52-Week Range
$0.43
$2.52
Volume
79,404 shs
Average Volume
45,197 shs
Market Capitalization
$13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.50

Centogene MarketRank™ Stock Analysis

Analyst Rating
0.00 Rating Score
Upside/​Downside
215.5% Upside
$1.50 Price Target
Short Interest
Healthy
0.10% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.26
Upright™ Environmental Score
News Sentiment
-0.01mentions of Centogene in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.60) to ($0.97) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.50 out of 5 stars

Medical Sector

539th out of 918 stocks

Medical Laboratories Industry

13th out of 20 stocks

CNTG stock logo

About Centogene Stock (NASDAQ:CNTG)

Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It operates through two segments: Pharmaceutical and Diagnostics. The company provides target and drug screening, clinical development, market access and expansion, as well as CENTOGENE Biodatabank licenses and insight report services. In addition, it offers various services, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.

CNTG Stock Price History

CNTG Stock News Headlines

Centogene (NASDAQ:CNTG) Short Interest Update
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
CENTOGENE Receives Nasdaq Non-Compliance Notice
Centogene (NASDAQ: CNTG)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Centogene NV: CENTOGENE Explores Strategic Alternatives
Centogene Explores Strategic Alternatives, Incl. Sale
Centogene Announces Receipt Of Nasdaq Notice Of Delisting
CENTOGENE Explores Strategic Alternatives
CENTOGENE Announces Preliminary Full Year 2023 Revenue
Centogene NV Ordinary Shares CNTG
See More Headlines
Receive CNTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Centogene and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/24/2021
Today
4/19/2024
Next Earnings (Estimated)
5/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical laboratories
Sub-Industry
N/A
Current Symbol
NASDAQ:CNTG
Fax
N/A
Employees
444
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.50
High Stock Price Target
$1.50
Low Stock Price Target
$1.50
Potential Upside/Downside
+215.5%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$50.03 million
Book Value
$0.29 per share

Miscellaneous

Free Float
N/A
Market Cap
$13 million
Optionable
Not Optionable
Beta
-0.81
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Ms. Kim Stratton (Age 62)
    CEO & Member of Management Board
    Comp: $933.13k
  • Mr. Jose Miguel Coego Rios
    CFO, Legal & IT and Member of Management Board
  • Dr. Peter Bauer M.D. (Age 54)
    Chief Medical & Genomic Officer and Member of Management Board
    Comp: $186.41k
  • Dr. Andrin Oswald M.D. (Age 52)
    Ph.D., Advisor
    Comp: $943.96k
  • Mr. Ian Rentsch
    Chief Commercial Officer & GM of Pharma

CNTG Stock Analysis - Frequently Asked Questions

What is Centogene's stock price target for 2024?

0 analysts have issued 12-month price objectives for Centogene's stock. Their CNTG share price targets range from $1.50 to $1.50. On average, they anticipate the company's share price to reach $1.50 in the next year. This suggests a possible upside of 215.5% from the stock's current price.
View analysts price targets for CNTG
or view top-rated stocks among Wall Street analysts.

How have CNTG shares performed in 2024?

Centogene's stock was trading at $1.20 at the beginning of the year. Since then, CNTG stock has decreased by 60.4% and is now trading at $0.4755.
View the best growth stocks for 2024 here
.

Are investors shorting Centogene?

Centogene saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 11,900 shares, an increase of 5.3% from the March 15th total of 11,300 shares. Based on an average daily volume of 44,800 shares, the days-to-cover ratio is currently 0.3 days. Approximately 0.1% of the shares of the stock are short sold.
View Centogene's Short Interest
.

When is Centogene's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 21st 2024.
View our CNTG earnings forecast
.

How were Centogene's earnings last quarter?

Centogene (NASDAQ:CNTG) issued its earnings results on Wednesday, November, 24th. The company reported ($1.08) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.59) by $0.49. The business had revenue of $35.60 million for the quarter, compared to analysts' expectations of $31.91 million. During the same quarter in the prior year, the business earned ($0.32) EPS.

What other stocks do shareholders of Centogene own?
When did Centogene IPO?

Centogene (CNTG) raised $60 million in an IPO on Thursday, November 7th 2019. The company issued 4,000,000 shares at $14.00-$16.00 per share. SVB Leerink and Evercore ISI acted as the underwriters for the IPO and Baird and BTIG were co-managers.

How do I buy shares of Centogene?

Shares of CNTG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CNTG) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners